Assessment of the consistency of medicinal chemists in reviewing sets of compounds.
about
Estimation of synthetic accessibility score of drug-like molecules based on molecular complexity and fragment contributionsAn activity canyon characterization of the pharmacological topographyMiscellaneous Topics in Computer-Aided Drug Design: Synthetic Accessibility and GPU Computing, and Other TopicsInside the mind of a medicinal chemist: the role of human bias in compound prioritization during drug discoveryIdentification of compounds with anti-proliferative activity against Trypanosoma brucei brucei strain 427 by a whole cell viability based HTS campaignComputational prediction and validation of an expert's evaluation of chemical probesNonpher: computational method for design of hard-to-synthesize structures.Utility-aware screening with clique-oriented prioritization.The essential roles of chemistry in high-throughput screening triageVirtual screening of chemical libraries for drug discovery.Non-stoichiometric inhibition in integrated lead finding - a literature review.Growing PAINS in academic drug discovery.mQC: A Heuristic Quality-Control Metric for High-Throughput Drug Combination Screening.Development of small-molecule therapies for autoimmune diseases.The influence of the 'organizational factor' on compound quality in drug discovery.Discovery strategies in a pharmaceutical setting: the application of computational techniques.Chemical predictive modelling to improve compound quality.In silico tools used for compound selection during target-based drug discovery and development.Medicinal Chemists of the 21(st) Century--Who Are We and Where to Go?Analyzing compound and project progress through multi-objective-based compound quality assessment.A Crowd-Based Process and Tool for HTS Hit Triage.The use of 2D fingerprint methods to support the assessment of structural similarity in orphan drug legislation.Enhancing the rate of scaffold discovery with diversity-oriented prioritization.Quantifying the chemical beauty of drugs.Drug discovery: Chemical beauty contest.Ligand efficiency metrics in drug discovery: the pros and cons from a practical perspective.In Silico ADME/Tox PredictionsProperties Guiding Drug- and Lead-LikenessDeep reinforcement learning for de novo drug designDecision Making in Medicinal Chemistry: The Power of Our IntuitionMOLECULAR SIMILARITY ANALYSIS
P2860
Q27702095-3E28B0D1-D051-4E61-A020-F4CEEAD2E21DQ27902342-0536B437-8833-4707-8081-5B5A97702A0FQ28073818-7622B441-9E0D-4919-BA1C-BC6EE7E0BA99Q28485305-6A963DD8-D2B6-4132-80AC-57949B562707Q28485372-3825D92D-F111-4378-9D7D-3E46F18ED6B7Q28829404-4C5163F2-349E-4582-977D-84AE7190BD21Q29407950-FCD5312E-A470-4582-9502-394D718F4C94Q34083863-1BCC050E-AED4-4A2B-9120-D913F3C66AA3Q34435458-E694F386-2480-4DC0-943E-A6DD00744787Q34626368-AF2C7D98-1246-427C-BA4D-BA3D314BB085Q35865278-1DFBC019-0C22-4EA2-A9E8-B1BFF1A0DF4BQ36886292-098DB651-FEA8-48D9-AA46-9FE32C723A76Q37436081-D790DE67-5105-4B8B-939C-75AB46409525Q37730104-3704B307-9D8C-43F2-8EF2-99319DCF7220Q37940789-9D8775AD-0E40-45E7-ADA3-A69024AEF39EQ38089826-7B8363C2-90D4-4F15-9099-E1C94BBE96D8Q38167262-0EEEA5F0-4078-4D4E-8BEC-58265825BBC7Q38465124-8622FE7F-C830-4D1E-8392-73DCD450FA5FQ39012845-7B2884CB-ACFA-451F-A404-5561BC0CCBACQ39423618-7EFEBEFF-E672-4DC5-88C4-05E909C8FA7AQ39535449-B148B8A7-08B6-4586-A6CF-4A0EA7C0B853Q41952646-0D8D0B42-3098-4397-9A26-3DF7AE089380Q42183610-11D902DC-09C0-487D-A60D-C9C41D5F1543Q42414958-5B1D572E-5035-4C22-B4CB-624F139EE99CQ43409217-84EAA615-FCA5-494E-90E4-4642750CEE81Q50502203-DA3BEA7C-B119-4990-AD2B-3B28ED270E8DQ56984194-14B7B07B-B505-4D02-8E2F-9E13998B3FA7Q57008200-BB6927A9-6EAF-4227-BDC7-BAB32FC88BEEQ57425404-9B970F84-BABA-4A3B-84A0-0A5147A894B4Q57822340-A092DDF9-46BF-4D7C-83D9-C7992D46DE7FQ57832782-C7F5E165-B0DB-4D43-B427-6C7D05B45895
P2860
Assessment of the consistency of medicinal chemists in reviewing sets of compounds.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Assessment of the consistency of medicinal chemists in reviewing sets of compounds.
@ast
Assessment of the consistency of medicinal chemists in reviewing sets of compounds.
@en
type
label
Assessment of the consistency of medicinal chemists in reviewing sets of compounds.
@ast
Assessment of the consistency of medicinal chemists in reviewing sets of compounds.
@en
prefLabel
Assessment of the consistency of medicinal chemists in reviewing sets of compounds.
@ast
Assessment of the consistency of medicinal chemists in reviewing sets of compounds.
@en
P356
P1476
Assessment of the consistency of medicinal chemists in reviewing sets of compounds
@en
P2093
Michael S Lajiness
P304
P356
10.1021/JM049740Z
P407
P577
2004-09-01T00:00:00Z